Furthermore, butyrate increased the production of GLP-1, peptide YY (PYY), and growth hormone; it also reduced appetite, activated brown adipose tissue, and diminished diet-induced obesity [21,32]. The gene discussed is PYY; the disease is obesity due to melanocortin 4 receptor deficiency.